Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 6, 2018
A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resectionLauren S Tufts, Emma D Jarnagin, Jessica R Flynn, et al.
Abdominal Radiology (New York)|September 28, 2020
Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgeryShannan M Dickinson, Caitlin A McIntyre, Juliana B Schilsky, et al.
Cancer|August 19, 2020
Clinical implications of drug-induced liver injury in early-phase oncology clinical trialsSebastian P Mondaca, Dazhi Liu, Jessica R Flynn, et al.
Blood Advances|July 31, 2023
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphomaMichael Scordo, Jessica R Flynn, Mithat Gonen, et al.
Transplantation and Cellular Therapy|July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With LymphomaRachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
British Journal of Cancer|December 29, 2021
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancersYonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, et al.
Bone Marrow Transplantation|February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphomaMagdalena Corona, Andrew Ip, Samantha Brown, et al.
Blood Cancer Journal|April 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphomaAlejandro Luna, Sean M Devlin, Kai Rejeski, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Blood Advances|August 25, 2021
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cellsMartina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, et al.
Pageof 4